Retrieve available abstracts of 30 articles: HTML format
Single Articles
May 2025
ZHANG C, Jiang H, Yuan L, Liao Y, et al Correction: CircVPRBP inhibits nodal metastasis of cervical cancer by impeding
RACK1 O-GlcNAcylation and stability.
Oncogene. 2025 May 15. doi: 10.1038/s41388-025-03440. PubMed
April 2025
ZHU Y, Abedini A, Rodriguez GM, McCloskey CW, et al Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT
activity and PD-L1 expression.
Oncogene. 2025 Apr 12. doi: 10.1038/s41388-025-03387. PubMedAbstract available
LI Y, Chen Z, Gao Y, Liu Y, et al SNRPB-mediated regulation of DDX39A splicing promotes ovarian cancer progression
by regulating alpha6 integrin subunit expression.
Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03386. PubMedAbstract available
WAGNER V, Morton M, Dorayappan KDP, Gonzalez A, et al Circulating extracellular vesicles protein expression for early prediction of
platinum-resistance in high-grade serous ovarian cancer.
Oncogene. 2025 Apr 10. doi: 10.1038/s41388-025-03382. PubMedAbstract available
March 2025
ZHAO X, Lai H, Li G, Qin Y, et al Rictor orchestrates beta-catenin/FOXO balance by maintaining redox homeostasis
during development of ovarian cancer.
Oncogene. 2025 Mar 25. doi: 10.1038/s41388-025-03351. PubMedAbstract available
WANG J, Yang F, Chen Y, Xing Y, et al A positive feedback loop of OTUD1 and c-Jun driven by leptin expedites stemness
maintenance in ovarian cancer.
Oncogene. 2025 Mar 19. doi: 10.1038/s41388-025-03342. PubMedAbstract available
ZHAI F, Li Y, Zheng J, Yan C, et al SPOP/NOLC1/B4GALT1 signaling axis enhances paclitaxel resistance in endometrial
cancer by inducing O-dysglycosylation.
Oncogene. 2025 Mar 17. doi: 10.1038/s41388-025-03347. PubMedAbstract available
FANG D, Chen H, Zhu JY, Wang W, et al Editorial Expression of Concern: Epithelial-mesenchymal transition of ovarian
cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and
Src signaling pathways.
Oncogene. 2025 Mar 3. doi: 10.1038/s41388-025-03333. PubMed
February 2025
XI Q, Kunita A, Ogawa M, Ka M, et al Cyclin E1 overexpression sensitizes ovarian cancer cells to WEE1 and PLK1
inhibition.
Oncogene. 2025 Feb 24. doi: 10.1038/s41388-025-03312. PubMedAbstract available
STEWART J, Krastev DB, Brough R, Zatreanu D, et al PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell
carcinoma.
Oncogene. 2025 Feb 12. doi: 10.1038/s41388-024-03265. PubMedAbstract available
January 2025
DONG P, Xiong Y, Yu J, Chen L, et al Editorial Expression of Concern: Control of PD-L1 expression by
miR-140/142/340/383 and oncogenic activation of the OCT4-miR-18a pathway in
cervical cancer.
Oncogene. 2025 Jan 29. doi: 10.1038/s41388-025-03285. PubMed
WANG M, Yan Q, Song Y, Zhang Z, et al Correction: Loss-of-function mutations of SOX17 lead to YAP/TEAD
activation-dependent malignant transformation in endometrial cancer.
Oncogene. 2025 Jan 27. doi: 10.1038/s41388-025-03280. PubMed
HAN X, Xia L, Wu Y, Chen X, et al m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1
and IL6/JAK2/STAT3 pathways.
Oncogene. 2025 Jan 15. doi: 10.1038/s41388-024-03260. PubMedAbstract available
December 2024
ZHAI X, Shen N, Guo T, Wang J, et al SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer
progression.
Oncogene. 2024 Dec 7. doi: 10.1038/s41388-024-03249. PubMedAbstract available
CHIA ML, Bulat F, Gaunt A, Ros S, et al Metabolic imaging distinguishes ovarian cancer subtypes and detects their early
and variable responses to treatment.
Oncogene. 2024 Dec 6. doi: 10.1038/s41388-024-03231. PubMedAbstract available
DUAN Q, Wang W, Xiong H, Xiao J, et al JAK2/ULK1 axis promotes cervical cancer progression by autophagy induction and
SRPK1 phosphorylation.
Oncogene. 2024 Dec 4. doi: 10.1038/s41388-024-03246. PubMedAbstract available
October 2024
SAKAUE T, Dorayappan KDP, Zingarelli R, Khadraoui W, et al Obesity-induced extracellular vesicles proteins drive the endometrial cancer
pathogenesis: therapeutic potential of HO-3867 and Metformin.
Oncogene. 2024 Oct 16. doi: 10.1038/s41388-024-03182. PubMedAbstract available
SHI J, Zhou R, Wang S, Liu Y, et al NEU4-mediated desialylation enhances the activation of the oncogenic receptors
for the dissemination of ovarian carcinoma.
Oncogene. 2024 Oct 14. doi: 10.1038/s41388-024-03187. PubMedAbstract available
LI Y, Yang H, Li A, Chen B, et al CypA/TAF15/STAT5A/miR-514a-3p feedback loop drives ovarian cancer metastasis.
Oncogene. 2024 Oct 14. doi: 10.1038/s41388-024-03188. PubMedAbstract available
LIU Y, Li J, Xu J, Long Y, et al m(6)A-driven NAT10 translation facilitates fatty acid metabolic rewiring to
suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7
mRNA acetylation.
Oncogene. 2024 Oct 10. doi: 10.1038/s41388-024-03185. PubMedAbstract available
SUN X, Ye G, Li J, Yuan L, et al The tumor suppressor Parkin exerts anticancer effects through regulating
mitochondrial GAPDH activity.
Oncogene. 2024;43:3215-3226. PubMedAbstract available
September 2024
SANG X, Han J, Wang Z, Cai W, et al SGK1 suppresses ferroptosis in ovarian cancer via NRF2-dependent and -independent
pathways.
Oncogene. 2024 Sep 21. doi: 10.1038/s41388-024-03173. PubMedAbstract available
CHEN J, Shan W, Jia Q, Chen Y, et al USP33 facilitates the ovarian cancer progression via deubiquitinating and
stabilizing CBX2.
Oncogene. 2024 Sep 10. doi: 10.1038/s41388-024-03151. PubMedAbstract available
August 2024
ONJI H, Tate S, Sakaue T, Fujiwara K, et al Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through
single-strand DNA gap accumulation behind replication forks.
Oncogene. 2024;43:2475-2489. PubMedAbstract available
June 2024
GHEZELAYAGH TS, Kohrn BF, Fredrickson J, Krimmel-Morrison JD, et al TP53 somatic evolution in cervical liquid-based cytology and blood from
individuals with and without ovarian cancer and BRCA1 or BRCA2 germline
mutations.
Oncogene. 2024 Jun 25. doi: 10.1038/s41388-024-03089. PubMedAbstract available
May 2024
PATTERSON MR, Meijers AS, Ryder EL, Wootton LM, et al E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in
HPV-positive cervical cancer.
Oncogene. 2024 May 24. doi: 10.1038/s41388-024-03067. PubMedAbstract available
ZHANG C, Xu Y, Zhu X, Zhang X, et al Phosphorylation of FOXK2 at Thr13 and Ser30 by PDK2 sustains glycolysis through a
positive feedback manner in ovarian cancer.
Oncogene. 2024 May 11. doi: 10.1038/s41388-024-03052. PubMedAbstract available
April 2024
SHAN W, Peng W, Chen Y, Wang Y, et al GSK3beta and UCHL3 govern RIPK4 homeostasis via deubiquitination to enhance tumor
metastasis in ovarian cancer.
Oncogene. 2024 Apr 25. doi: 10.1038/s41388-024-03040. PubMedAbstract available
CHEN H, Lee LJ, Vincent KM, Xu Z, et al Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with
both bulk and cancer stem cells in epithelial ovarian cancer.
Oncogene. 2024 Apr 9. doi: 10.1038/s41388-024-03026. PubMedAbstract available
WEI Y, Chen Z, Li Y, Song K, et al The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant
progression of ovarian cancer.
Oncogene. 2024 Apr 1. doi: 10.1038/s41388-024-03015. PubMedAbstract available